Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA)
Open Journal of Immunology · 2012
DOI: 10.4236/oji.2012.23011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Journal of Immunology, 2012. Verfasst von Pauline T. Lukey und 11 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lukey, P. T., Perry, H. C., Yang, S., Parry, S., Dickson, M. C., Norris, V. H., Russell, P. G., Watissée, M., Rioja, I., Ray, K. P., Crowe, S., & Binks, M. (2012). Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA). Open Journal of Immunology. https://doi.org/10.4236/oji.2012.23011
Vancouver
Lukey PT, Perry HC, Yang S, Parry S, Dickson MC, Norris VH, et al. Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA). Open Journal of Immunology. 2012. doi:10.4236/oji.2012.23011
BibTeX
@article{Lukey2012,
author = {Lukey, Pauline T. and Perry, Hayley C. and Yang, Shuying and Parry, Simon and Dickson, Marion C. and Norris, Virginia H. and Russell, Paul G. and Watissée, Marie and Rioja, Inmaculada and Ray, Keith P. and Crowe, Scott and Binks, Michael},
title = {Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA)},
journal = {Open Journal of Immunology},
year = {2012},
doi = {10.4236/oji.2012.23011}
}
EUVIMED